Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Duloxetine effective in reducing osteoarthritis knee pain

July 1, 2008

PN-277 shows benefit in experimental Parkinson's disease

June 30, 2008

New data on axitinib in metastatic cancers presented

June 30, 2008

Combination of IMC-11F8 and mFOLFOX-6 appears well tolerated in colorectal cancer

June 30, 2008

XOMA-052 shows antiarthritic effects in murine CIA model

June 30, 2008

Kinesin spindle protein inhibitor AZD-4877 evaluated in phase I studies at AstraZeneca

June 27, 2008

Pierre Fabre reports phase I results for omtriptolide in acute leukemias

June 27, 2008

Bivalent cholera vaccine shows immunogenicity and protection against Vibrio cholerae infection

June 27, 2008

PF-03814735 doses, tolerability explored in solid tumor patients

June 27, 2008

Canakinumab demonstrates clinical benefit in patients with Muckle-Wells syndrome / News in Context

June 27, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.